Literature DB >> 11955953

Sphingosine 1-phosphate dynamically regulates myosin light chain phosphatase activity in human endothelial cells.

Markus Essler1, Michaela Retzer, Heiko Ilchmann, Stefan Linder, Peter C Weber.   

Abstract

Sphingosine 1-phosphate (S1P) is known to induce reorganization of the actin cytoskeleton through activation of the GTPase Rho. We have investigated the dynamic behavior of Rho/Rho kinase-regulated myosin light chain (MLC) phosphatase activity and MLC phosphorylation in Human Umbilical Vein Endothelial Cells (HUVEC) stimulated with S1P. Immediately (30-60 s) after S1P stimulation, MLC phosphatase activity dropped and MLC phosphorylation increased in a Rho/Rho kinase-dependent manner. Shortly thereafter (2 min), MLC phosphatase increased above baseline and MLC phosphorylation correspondingly decreased to near control values. At this time point, formation of actin ruffles and Rac activity assays indicated activation of Rac. Finally, between 5 and 15 min, MLC phosphatase dropped to a plateau below baseline. In parallel, MLC phosphorylation became constantly elevated above control values. These findings indicate that S1P is able to induce dynamic cycles of MLC phosphatase deactivation and activation. This novel feature of S1P could contribute to its chemotactic and angiogenic activity.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11955953     DOI: 10.1016/s0898-6568(02)00013-x

Source DB:  PubMed          Journal:  Cell Signal        ISSN: 0898-6568            Impact factor:   4.315


  2 in total

1.  Sphingosine 1-phosphate, a diffusible calcium influx factor mediating store-operated calcium entry.

Authors:  Kiyoshi Itagaki; Carl J Hauser
Journal:  J Biol Chem       Date:  2003-05-13       Impact factor: 5.157

2.  OxLDL-dependent activation of arginase II is dependent on the LOX-1 receptor and downstream RhoA signaling.

Authors:  Sungwoo Ryoo; Anil Bhunia; Fumin Chang; Artin Shoukas; Dan E Berkowitz; Lewis H Romer
Journal:  Atherosclerosis       Date:  2010-11-04       Impact factor: 5.162

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.